Department of Cardiovascular Medicine, The Second Xiangya Hospital, Central South University, No. 139 Middle Renmin Road, Changsha 410011, Hunan, China; Research Institute of Blood Lipid and Atherosclerosis, Central South University, No. 139 Middle Renmin Road, Changsha 410011, Hunan, China; Hunan Key Laboratory of Cardiometabolic Medicine, No. 139 Middle Renmin Road, Changsha 410011, Hunan, China.
Department of Spine Surgery, The Second Xiangya Hospital, Central South University, No. 139 Middle Renmin Road, Changsha 410011, Hunan, China.
Metabolism. 2023 Jul;144:155564. doi: 10.1016/j.metabol.2023.155564. Epub 2023 Apr 23.
Mitochondrial dysfunction and aberrant structure in adipose tissue occur in obesity and obesity-linked brown adipose tissue (BAT) whitening; however, whether this aberrant architecture contributes to or is the result of obesity is unknown. Apolipoprotein O (APOO) is a constitutive protein of the mitochondrial cristae organizing system complex. This study aimed to characterize the physiological consequences of APOO deficiency in vivo.
APOO expression was analyzed in different human and murine adipose depots, and mice lacking APOO in adipocytes (Apoo) are developed to examine the metabolic consequences of adipocyte-specific APOO ablation in vitro and in vivo.
Results showed that APOO expression is reduced in BAT from both diet-induced and leptin-deficient obese mice. APOO-knockout mice showed increased adiposity, BAT dysfunction and whitening, reduced non-shivering thermogenesis, and blunted responses to cold stimuli. APOO deficiency disrupted mitochondrial structure in brown adipocytes and impaired oxidative phosphorylation, thereby inducing a shift from oxidative to glycolytic metabolism, increasing lipogenic enzyme levels and BAT whitening. APOO inactivation inhibited thermogenesis in BAT by reducing mitochondrial long-chain fatty acid oxidation. It also disturbed peroxisomal biogenesis and very long-chain fatty acid oxidation via peroxisome proliferator-activated receptor α.
Altogether, APOO deficiency in adipocytes aggravates BAT whitening and diet-induced obesity; thus, APOO could be a therapeutic target for obesity.
脂肪组织中线粒体功能障碍和结构异常发生在肥胖和肥胖相关的棕色脂肪组织(BAT)白化中;然而,这种结构异常是导致肥胖的原因,还是肥胖的结果尚不清楚。载脂蛋白 O(APOO)是线粒体嵴组织系统复合物的组成性蛋白。本研究旨在体内研究 APOO 缺乏的生理后果。
分析了不同人和鼠脂肪组织中 APOO 的表达,并构建了脂肪细胞特异性 APOO 缺失的 Apoo 小鼠,以研究体外和体内脂肪细胞特异性 APOO 缺失的代谢后果。
结果表明,饮食诱导和瘦素缺乏肥胖小鼠的 BAT 中 APOO 的表达减少。APOO 敲除小鼠表现出肥胖增加、BAT 功能障碍和白化、非颤抖性产热减少以及对冷刺激的反应迟钝。APOO 缺乏破坏了棕色脂肪细胞中的线粒体结构,并损害了氧化磷酸化,从而导致从氧化到糖酵解代谢的转变,增加了脂肪生成酶的水平和 BAT 白化。APOO 失活通过减少线粒体长链脂肪酸氧化来抑制 BAT 的产热。它还通过过氧化物酶体增殖物激活受体α干扰过氧化物酶体的生物发生和极长链脂肪酸氧化。
总之,脂肪细胞中的 APOO 缺乏会加重 BAT 白化和饮食诱导的肥胖;因此,APOO 可能是肥胖的治疗靶点。